Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4312596 | Behavioural Brain Research | 2013 | 4 Pages |
•Urocortin 3 elicits anxiolytic action in the plus maze in mice.•The action is mediated by dopaminergic, cholinergic, beta-adrenergic and serotonergic receptors.•Alfa-adrenergic and GABA-A-ergic mediation is not involved.
Urocortin 3 (Ucn 3) was tested for anxiolytic action in mice an elevated plus maze. For detection of the possible involvement of neurotransmitters, the mice were pretreated with receptor blockers: haloperidol, phenoxybenzamine, propranolol, atropine, methysergide, bicuculline or naloxone. The peptide was administered into the lateral brain ventricle; the receptor blockers were applied intra- peritoneally.Ucn 3 alone elicited dose-dependent bell-shaped anxiolytic action. The most effective dose was 0.5 μg. In the combined testing a 0.5 μg dose was used. Haloperidol, propranolol, atropine, methysergide, and naloxone, blocked the Ucn 3-induced anxiolytic action, while phenoxybenzamine and bicuculline were ineffective. The results suggest that dopaminergic, beta-adrenergic, cholinergic, serotonergic and opiate transmissions are involved in the anxiolytic action of Ucn 3.